Literature DB >> 10845836

Remission of nephrotic syndrome after removal of localized Castleman's disease.

K Keven1, G Nergizoğlu, K Ateş, S Erekul, D Orhan, S Ertürk, O Tulunay, O Karatan, A E Ertuğ.   

Abstract

Renal complications of Castleman's disease are uncommon. Among the various renal disorders, including mesangial proliferative glomerulonephritis, membranous glomerulonephritis, and minimal change disease, nephrotic syndrome attributable to renal amyloidosis is very rarely reported. We report a case of mixed type of localized Castleman's disease complicated with nephrotic syndrome. Renal biopsy was performed. The deposition of AA amyloidosis was shown. After the removal of two mesenteric lymphoid masses, the proteinuria was gradually decreased and disappeared. Renal biopsy was repeated after 14 months, and, despite complete remission of nephrotic syndrome, no regression in amyloid deposition was found.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10845836     DOI: 10.1016/s0272-6386(00)70059-x

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  5 in total

Review 1.  An autopsy case of multicentric Castleman's disease associated with interstitial nephritis and secondary AA amyloidosis.

Authors:  Yuriko Morita-Hoshi; Shuji Tohda; Osamu Miura; Nobuo Nara
Journal:  Int J Hematol       Date:  2007-12-08       Impact factor: 2.490

2.  Remission of secondary membranous nephropathy in a patient with Kimura disease after surgical resection.

Authors:  Sunhwa Lee; Yong Jin Yi; Hyung Ah Jo; Hyuk Huh; Kyung-Hwan Kim; Dong Ki Kim; Hajeong Lee
Journal:  Kidney Res Clin Pract       Date:  2014-08-23

3.  Interleukin-6 receptor inhibition with tocilizumab in various renal involvements associated with multicentric Castleman's disease: a report of three cases.

Authors:  Hirotaka Komaba; Takashi Nakazawa; Yutaka Yamaguchi; Shunichi Kumagai; Masafumi Fukagawa
Journal:  NDT Plus       Date:  2008-10-08

4.  Unicentric Castleman's disease associated with end stage renal disease caused by amyloidosis.

Authors:  Eray Eroglu; Ismail Kocyigit; Aydin Unal; Murat Hayri Sipahioglu; Hulya Akgun; Leylagul Kaynar; Bulent Tokgoz; Oktay Oymak
Journal:  World J Clin Cases       Date:  2017-03-16       Impact factor: 1.337

Review 5.  AA amyloidosis associated with Castleman disease: A case report and review of the literature.

Authors:  Luca Bernabei; Adam Waxman; Gabriel Caponetti; David C Fajgenbaum; Brendan M Weiss
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.